Researchers ID Dormant HIV Cells
- Published on March 6, a groundbreaking study reveals a new method developed by Mount Sinai researchers to identify hidden immune cells harboring HIV.
- HIV weakens the immune system by attacking cells that fight off infections.
- The research team introduced a novel cell lineage-tracing model to pinpoint were the virus hides.
Breakthrough in HIV Research: Targeting Dormant Cells for a Potential Cure
Table of Contents
Published on March 6, a groundbreaking study reveals a new method developed by Mount Sinai researchers to identify hidden immune cells harboring HIV. this revelation marks a meaningful step toward finding a cure for the infection affecting nearly 40 million people worldwide.
Understanding the Challenge of HIV
HIV weakens the immune system by attacking cells that fight off infections. While antiretroviral therapies effectively halt the virus’s spread and protect the immune system, they do not eradicate the virus completely. The new method developed by Mount Sinai researchers focuses on genetically marking immune cells that carry HIV, possibly leading to strategies that eliminate these dormant, infected cells.
Novel Approach to Identify Dormant HIV Cells
The research team introduced a novel cell lineage-tracing model to pinpoint were the virus hides. They developed genetic profiles of T cells, crucial white blood cells responsible for immune response, distinguishing between those with active and inactive HIV. This genetic analysis offers a new pathway for potential treatment by targeting dormant HIV-infected cells.
“The main obstacle to cure the infection is the virus hides in immune cells that are challenging to identify and study. If we can identify the cells infected with HIV, it will help bring us closer to figuring out how to eliminate them,”
Benjamin K. Chen, MD, PhD, Professor of Medicine
Innovative Genetic System for Tracking HIV
Researchers created a genetic system to mark HIV-infected cells, enabling the study of both infected and dormant cell populations. Using humanized mice models, they developed a fluorescent red-to-green switch triggered by HIV infection, which persists even when the virus is dormant. This switch permanently marks HIV-infected cells in mice, facilitating lineage tracing of the HIV infection.
Comprehensive Profiling of T cells
the research team profiled over 47,000 T cells, including acutely infected, treated, and uninfected cells. This comprehensive analysis allowed them to identify various types of T cells, such as:
- Helper T cells (detect infections)
- Memory cells
- Naïve cells (fight off infections)
- Proliferating cells
- Regulatory T cells
Through their analysis, they identified nine distinct types of T cells that housed inactive HIV cells. The examination also identified persistent T cells with HIV even after 10 and 29 days of antiretroviral therapies.
Future Directions in HIV Cure Research
These findings suggest new therapies that target the reservoir of dormant HIV-infected cells as a potential cure for the virus. The Mount Sinai team plans to further study and test specific approaches to reactivate dormant HIV and determine if it is possible to reduce the reservoir of infected cells.
Funding and Support
The study received support from the National institute of Allergy and Infectious Diseases, the National Institutes of Health (AI116191, AI162223, S10OD026880, and S10OD030463), and the Clinical and Translational Science Awards (CTSA) grant from the National Center for Advancing Translational Sciences (UL1TR004419).
“`html
HIV Research Breakthrough: Q&A on Targeting Dormant Cells
A groundbreaking study published on March 6th details a novel method developed by Mount Sinai researchers to identify immune cells harboring dormant HIV. This Q&A explores the significance of this research and its potential impact on finding a cure for HIV.
Understanding the HIV dormancy Challenge
Why is it so challenging to cure HIV?
HIV weakens the immune system by attacking infection-fighting cells. Antiretroviral therapies (ART) can effectively suppress the virus and protect the immune system, but they cannot completely eliminate HIV. The virus has the ability to hide in a dormant state within immune cells, forming a reservoir that is difficult to target. This reservoir means that if ART is stopped, the virus can reactivate and begin replicating again.
What are dormant HIV cells?
Dormant HIV cells, also known as latent HIV reservoirs, are immune cells (primarily T cells) that are infected with HIV but are not actively producing new virus particles. These cells are essentially “sleeping” and are not affected by antiretroviral therapies, which only target actively replicating virus. As they are hidden and inactive, these cells are extremely challenging to identify and eliminate, representing a major obstacle to curing HIV.
The Mount sinai Research: A Novel Approach
What is the new method developed by Mount Sinai researchers?
The Mount Sinai researchers developed a novel method for genetically marking immune cells that carry HIV. This innovative approach uses a cell lineage-tracing model to pinpoint where the virus hides within the body. By genetically profiling T cells, they can distinguish between those with active and inactive HIV. This provides a pathway for potential treatments to specifically target and eliminate these dormant, infected cells.
How does the cell lineage-tracing model work?
The research team introduced a genetic system to mark HIV-infected cells. They used humanized mice models to develop a fluorescent red-to-green switch that is triggered by HIV infection. Even when the virus becomes dormant, the “switch” remains on, permanently marking the infected cells. This marking allows the researchers to trace the lineage of the HIV infection and study both infected and dormant cell populations.
What are humanized mice models?
Humanized mice are laboratory mice that have been engineered to carry human genes, cells, or tissues. In this study, they are essential as they allowed researchers to study the dynamics of HIV infection in a living system that mimics the human immune system more closely than traditional laboratory models. This model offers a more accurate platform for testing potential therapeutic interventions.
T Cell Profiling and HIV reservoirs
Why is T cell profiling important in HIV research?
T cells are a crucial part of the immune system and are the primary target of HIV. By comprehensively profiling T cells, researchers can identify the specific types of T cells that are harboring dormant HIV. Understanding the characteristics of these infected T cells is crucial for developing targeted therapies aimed at eliminating the HIV reservoir.
What types of T cells were analyzed in the study?
The research team profiled over 47,000 T cells, including acutely infected, treated, and uninfected cells. They identified and analyzed various types of T cells, including:
- Helper T cells: Detect infections and coordinate the immune response.
- Memory cells: “Remember” past infections and mount a rapid response upon re-exposure.
- Naïve cells: Fight off infections they encounter for the first time.
- Proliferating cells: Cells that are actively dividing.
- Regulatory T cells